M. Morgan

发表

Microcalcifications Associated with Breast Cancer: An Epiphenomenon or Biologically Significant Feature of Selected Tumors?

M. Morgan, M. Cooke, G. Mccarthy, 2005, Journal of Mammary Gland Biology and Neoplasia.

Calcium hydroxyapatite promotes mitogenesis and matrix metalloproteinase expression in human breast cancer cell lines

M. Morgan, M. Cooke, G. Mccarthy, 2001, Molecular carcinogenesis.

Mechanism of basic calcium phosphate crystal-stimulated matrix metalloproteinase-13 expression by osteoarthritic synovial fibroblasts: inhibition by prostaglandin E2

D. Fitzgerald, M. Morgan, G. Mccarthy, 2008, Annals of the rheumatic diseases.

The role of transcription factors in the acquisition of the four latest proposed hallmarks of cancer and corresponding enabling characteristics.

M. Morgan, Sudipto Das, E. Finnegan, 2022, Seminars in cancer biology.

Mechanism of basic calcium phosphate crystal-stimulated cyclo-oxygenase-1 up-regulation in osteoarthritic synovial fibroblasts.

D. Fitzgerald, M. Morgan, G. Mccarthy, 2008, Rheumatology.

Microsomal prostaglandin E2 synthase 1 expression in basic calcium phosphate crystal-stimulated fibroblasts: role of prostaglandin E2 and the EP4 receptor.

D. Fitzgerald, M. Morgan, G. Mccarthy, 2009, Osteoarthritis and cartilage.

BCP crystals increase prostacyclin production and upregulate the prostacyclin receptor in OA synovial fibroblasts: potential effects on mPGES1 and MMP-13.

M. Morgan, G. Mccarthy, B. McDonnell, 2007, Osteoarthritis and cartilage.

Modulation of Matrix Metalloproteinases in Trophoblast Cell Lines

S. Mcdonnell, M. Morgan, 1999, Annals of the New York Academy of Sciences.

Signaling mechanisms involved in crystal-induced tissue damage

M. Morgan, G. Mccarthy, G. McCarthy, 2002, Current opinion in rheumatology.

Basic calcium phosphate crystals as a unique therapeutic target in osteoarthritis.

M. Morgan, G. Mccarthy, Linda C Whelan, 2005, Frontiers in bioscience : a journal and virtual library.

Novel trans-platinum complexes of the histone deacetylase inhibitor valproic acid; synthesis, in vitro cytotoxicity and mutagenicity.

M. Morgan, B. Duff, D. Egan, 2011, Journal of inorganic biochemistry.

Microcalcifications in breast cancer: Lessons from physiological mineralization.

M. Morgan, R. Cox, Rachel Cox, 2013, Bone.

Human ciliary body epithelium in culture.

M. Morgan, W. McCombs, C. McCoy, 1983, Investigative ophthalmology & visual science.

Deposition of calcium in an in vitro model of human breast tumour calcification reveals functional role for ALP activity, altered expression of osteogenic genes and dysregulation of the TRPM7 ion channel

M. Morgan, S. O’Grady, Shane O’Grady, 2019, Scientific Reports.

The Cancer Stem Cell Niche in Ovarian Cancer and Its Impact on Immune Surveillance

M. Morgan, T. Robson, Stephanie Annett, 2021, International journal of molecular sciences.

A novel anti-cancer bifunctional platinum drug candidate with dual DNA binding and histone deacetylase inhibitory activity.

M. Morgan, D. Griffith, C. Marmion, 2009, Chemical communications.

Basic calcium phosphate crystal-induced prostaglandin E2 production in human fibroblasts: role of cyclooxygenase 1, cyclooxygenase 2, and interleukin-1beta.

D. Fitzgerald, M. Morgan, G. Mccarthy, 2004, Arthritis and rheumatism.

Phosphocitrate Inhibits Calcium Hydroxyapatite Induced Mitogenesis and Upregulation of Matrix Metalloproteinase-1, Interleukin-1β and Cyclooxygenase-2 mRNA in Human Breast Cancer Cell Lines

M. Morgan, G. Mccarthy, Michelle M. Cooke, 2003, Breast Cancer Research and Treatment.

A novel platinum complex of the histone deacetylase inhibitor belinostat: rational design, development and in vitro cytotoxicity.

M. Morgan, M. Brennan, A. Chubb, 2013, Journal of inorganic biochemistry.

Microcalcifications in breast cancer: From pathophysiology to diagnosis and prognosis.

M. Morgan, S. O’Grady, 2018, Biochimica et biophysica acta. Reviews on cancer.

Calcium transport and signalling in breast cancer: functional and prognostic significance.

M. Morgan, S. O’Grady, 2019, Seminars in cancer biology.

Defining the molecular target of an antibody derived from nuclear extract of Jurkat cells using protein arrays.

D. Mason, D. Murphy, M. Morgan, 2009, Analytical biochemistry.

Osteomimicry of Mammary Adenocarcinoma Cells In Vitro; Increased Expression of Bone Matrix Proteins and Proliferation within a 3D Collagen Environment

F. O'Brien, M. Morgan, K. Pohl, 2012, PloS one.

A time-course Raman spectroscopic analysis of spontaneous in vitro microcalcifications in a breast cancer cell line

N. Stone, M. Morgan, K. Rogers, 2021, Laboratory Investigation.

Derivatisation of buforin IIb, a cationic henicosapeptide, to afford its complexation to platinum(ii) resulting in a novel platinum(ii)-buforin IIb conjugate with anti-cancer activity.

M. Morgan, M. Devocelle, C. Marmion, 2016, Dalton transactions.

Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets

M. Morgan, T. Robson, Weipeng Wang, 2023, Frontiers in Endocrinology.

M. Morgan, S. O’Grady, 2019, Scientific Reports.

Polymeric prodrug combination to exploit the therapeutic potential of antimicrobial peptides against cancer cells.

S. McClean, M. Morgan, M. Devocelle, 2016, Organic & biomolecular chemistry.

Microcalcifications in breast cancer: novel insights into the molecular mechanism and functional consequence of mammary mineralisation

M. Morgan, J. Harmey, J H Harmey, 2012, British Journal of Cancer.

Defining the molecular target of an antibody derived from nuclear extract of Jurkat cells using protein arrays.

D. Mason, D. Murphy, M. Morgan, 2009, Analytical biochemistry.